financetom
Business
financetom
/
Business
/
Specialty chemicals firm Innospec Q3 adjusted EPS misses estimates on gross margins decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Specialty chemicals firm Innospec Q3 adjusted EPS misses estimates on gross margins decline
Nov 4, 2025 2:20 PM

Overview

* Innospec ( IOSP ) Q3 sales slightly beat analyst expectations, reaching $441.9 mln

* Adjusted EPS for Q3 missed analyst expectations at $1.12

* Company increased semi-annual dividend by 10% and repurchased $10.7 mln in shares

Outlook

* Innospec ( IOSP ) expects sequential operating income growth in Performance Chemicals and Oilfield Services

* Innospec ( IOSP ) does not assume resumption of Mexican sales in its outlook

Result Drivers

* FUEL SPECIALTIES - Strong operating income growth and margin expansion offset weaker results in other segments

* PERFORMANCE CHEMICALS - Sales grew but gross margins declined due to higher costs and weaker product mix

* OILFIELD SERVICES - Operating income declined due to lower Middle East activity and customer timing issues

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $441.90 $439.63

mln mln (3

Analysts

)

Q3 Miss $1.12 $1.18 (3

Adjusted Analysts

EPS )

Q3 EPS $0.52

Q3 Net $12.90

Income mln

Q3 Gross $116.70

Profit mln

Q3 $5.90

Operatin mln

g Income

Q3 $11.50

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy"

* Wall Street's median 12-month price target for Innospec Inc ( IOSP ) is $107.50, about 31.5% above its November 3 closing price of $73.65

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Mar 18, 2024
Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & Co ( BMY )  2seventy bio Inc’s  Abecma (idecabtagene vicleucel). The panel said Abecma demonstrated a favorable benefit/risk profile for patients with triple-class exposed relapsed or refractory multiple myeloma based on the pivotal Phase 3 KarMMa-3 study results, including the key secondary endpoint of overall...
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Mar 18, 2024
10:13 AM EDT, 03/18/2024 (MT Newswires) -- Sarah Gilligan, Chief Sup Chn & Transform Ofcr, on March 14, 2024, sold 31,167 shares in Gap (GPS) for $704,603. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000003991124000041/xslF345X03/edgardoc.xml Price: 24.57, Change: +0.98, Percent Change: +4.15 ...
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Mar 18, 2024
10:14 AM EDT, 03/18/2024 (MT Newswires) -- Nuvei Corp. ( NVEI ) announced overnight Sunday that it is aware of recent media reports speculating as to a potential going-private transaction involving the company. This comes after Reuters on Saturday cited a source familiar with the matter as saying private equity firm Advent International is in advanced talks to buy Nuvei...
Why Canoo (GOEV) Stock Is Skyrocketing
Why Canoo (GOEV) Stock Is Skyrocketing
Mar 18, 2024
Canoo Inc ( GOEV ) shares are trading higher by 56% to $3.03 during Monday’s session after the U.S. Department of Commerce has approved its Oklahoma City facility as a Foreign Trade Zone. The company says FTZ designation enables Canoo ( GOEV ) to eliminate customs duties on vehicles sold internationally and defer duties on imported parts used in domestic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved